Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Prostate cancer gene therapy trial commences

Dec. 19, 1996

Antineoplastic anthracycline antibiotic disclosed by Mercian

Dec. 19, 1996

Mercian reports new antitumor anthracycline

Dec. 19, 1996

Chemopreventive effects of Targretin in breast cancer

Dec. 18, 1996

Mercian discloses novel antitumor anthracycline antibiotics

Dec. 18, 1996

Antiangiogenic compounds described by Taiho

Dec. 18, 1996

CAK1 gene for treatment and diagnosis of cancers available for licensing

Dec. 17, 1996

SuperGen licenses metalloorganic compounds

Dec. 17, 1996

Angiogenesis inhibitors under study at ADIR

Dec. 17, 1996

Zeneca reports antiproliferative tyrosine kinase inhibitors

Dec. 17, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 11, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...